Atreca Inc. (BCEL): How investors can get the most out of their investments

For the readers interested in the stock health of Atreca Inc. (BCEL). It is currently valued at $3.45. When the transactions were called off in the previous session, Stock hit the highs of $3.56, after setting-off with the price of $2.86. Company’s stock value dipped to $2.86 during the trading on the day. When the trading was stopped its value was $2.87.Recently in News on March 4, 2022, Atreca to Participate in Cowen 42nd Annual Healthcare Conference. Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced that John Orwin, President and CEO, will participate in a panel discussion at Cowen’s 42nd Annual Healthcare Conference, being held virtually March 7-9, 2022. You can read further details here

Atreca Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.36 on 03/04/22, with the lowest value was $1.56 for the same time period, recorded on 02/22/22.

Atreca Inc. (BCEL) full year performance was -78.42%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Atreca Inc. shares are logging -80.76% during the 52-week period from high price, and 121.15% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.56 and $17.93.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2086027 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Atreca Inc. (BCEL) recorded performance in the market was 13.86%, having the revenues showcasing 7.14% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 108.40M, as it employees total of 134 workers.

The Analysts eye on Atreca Inc. (BCEL)

During the last month, 0 analysts gave the Atreca Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 3.23, with a change in the price was noted -1.75. In a similar fashion, Atreca Inc. posted a movement of -33.65% for the period of last 100 days, recording 1,385,096 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BCEL is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical rundown of Atreca Inc. (BCEL)

Raw Stochastic average of Atreca Inc. in the period of last 50 days is set at 49.74%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 49.74%. In the last 20 days, the company’s Stochastic %K was 40.00% and its Stochastic %D was recorded 35.61%.

Considering, the past performance of Atreca Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 13.86%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -45.15%, alongside a downfall of -78.42% for the period of the last 12 months. The shares increased approximately by 15.38% in the 7-day charts and went down by 90.61% in the period of the last 30 days. Common stock shares were driven by 7.14% during last recorded quarter.

Leave a Reply

Your email address will not be published. Required fields are marked *